Arrakis Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 15

Arrakis Therapeutics General Information

Description

Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform integrates RNA bioinformatics, chemical biology tools, chemical and biological assays, and RNA-directed medicinal chemistry, enabling physicians to treat a range of diseases including neurology, oncology, and rare genetic diseases.

Contact Information

Website
www.arrakistx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 828 Winter Street
  • Waltham, MA 02451
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • 828 Winter Street
  • Waltham, MA 02451
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrakis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Jan-2020 Completed Product Development
3. Early Stage VC (Series B) 10-Apr-2019 Completed Product Development
2. Early Stage VC (Series A) 02-Mar-2017 $38.5M $40.5M Completed Product Development
1. Seed Round 01-Jan-2015 $2M $2M Completed Startup
To view Arrakis Therapeutics’s complete valuation and funding history, request access »

Arrakis Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Arrakis Therapeutics’s complete cap table history, request access »

Arrakis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform i
Drug Discovery
Waltham, MA
100 As of 2023

South San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arrakis Therapeutics Competitors (125)

One of Arrakis Therapeutics’s 125 competitors is Amunix Pharmaceuticals, a Formerly PE-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amunix Pharmaceuticals Formerly PE-Backed South San Francisco, CA
Anavex Life Sciences Corporation New York, NY
Nanoviricides Corporation Shelton, CT
Compass Therapeutics Formerly VC-backed Boston, MA
WaVe Life Sciences Formerly VC-backed Cambridge, MA
You’re viewing 5 of 125 competitors. Get the full list »

Arrakis Therapeutics Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Arrakis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026097054-A1 Isoquinoline dmpk binders Pending 04-Nov-2024
WO-2026097056-A1 Isoquinoline tcf4 binders Pending 04-Nov-2024
WO-2026072885-A1 Cnot9 binding rna degraders Pending 27-Sep-2024
WO-2025184391-A1 Covalent inhibitors and uses thereof Pending 27-Feb-2024
WO-2025184391-A9 Covalent inhibitors and uses thereof Pending 27-Feb-2024 A61K47/545
To view Arrakis Therapeutics’s complete patent history, request access »

Arrakis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arrakis Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
GV Corporate Venture Capital Minority
HBM Healthcare Investments Venture Capital Minority
HBM Partners Venture Capital Minority
Nextech Invest Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Arrakis Therapeutics FAQs

  • When was Arrakis Therapeutics founded?

    Arrakis Therapeutics was founded in 2015.

  • Where is Arrakis Therapeutics headquartered?

    Arrakis Therapeutics is headquartered in Waltham, MA.

  • What is the size of Arrakis Therapeutics?

    Arrakis Therapeutics has 100 total employees.

  • What industry is Arrakis Therapeutics in?

    Arrakis Therapeutics’s primary industry is Drug Discovery.

  • Is Arrakis Therapeutics a private or public company?

    Arrakis Therapeutics is a Private company.

  • What is Arrakis Therapeutics’s current revenue?

    The current revenue for Arrakis Therapeutics is .

  • How much funding has Arrakis Therapeutics raised over time?

    Arrakis Therapeutics has raised $115M.

  • Who are Arrakis Therapeutics’s investors?

    Alexandria Venture Investments, GV, HBM Healthcare Investments, HBM Partners, and Nextech Invest are 5 of 15 investors who have invested in Arrakis Therapeutics.

  • Who are Arrakis Therapeutics’s competitors?

    Amunix Pharmaceuticals, Anavex Life Sciences, Nanoviricides, Compass Therapeutics, and WaVe Life Sciences are some of the 125 competitors of Arrakis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process